홈 › 비소세포폐암 › 미주리

미주리의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 84개가 미주리 내 여러 지역에서 참여자를 모집하고 있습니다.

미주리의 도시

공식 연구 텍스트(영어)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Washington University Center for Advanced Medicine, St Louis

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06765109

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Missouri Cancer Associates, Columbia

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361510

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Saint Francis Medical Center, Cape Girardeau
Saint Luke's Hospital, Chesterfield
외 18개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT04267848

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Missouri Cancer Associates, Columbia

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361497

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Saint Francis Medical Center, Cape Girardeau

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07388524

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, St Louis

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Washington University School of Medicine - Siteman Cancer Center, St Louis

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06881784

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
University Health Truman Medical Center, Kansas City
Mercy Hospital South, St Louis
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Missouri Cancer Associates, Columbia

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07144280

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Washington University School Of Medicine, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05498428

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, St Louis

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Saint Luke's Hospital of Kansas City, Kansas City
Saint Luke's East Hospital, Lee's Summit

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06758401

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Bridgeton

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06868277

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Washington University School of Medicine, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07154290

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Truman Medical Ctr West, Kansas City
Oncology Hematology Associates, Springfield
Washington University School Of Medicine, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667076

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Washington University, St Louis

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312137

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Washington University in St Louis, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667908

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Washington University, School of Medicine, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
외 18개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Missouri Baptist Medical Center, St Louis

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06890598

Pan-tumor MRD Study

Cox Health, Springfield

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Washington University School of Medicine, St Louis

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07140016

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Kansas City

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06357533

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Local Institution - 0140, St Louis

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06618287

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Local Institution - 0498, Kansas City

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06561386

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Washington University School of Medicine, St Louis

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07100080

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Missouri Cancer Associates, Columbia
SSM Health Cancer Care - St. Clare, Fenton

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06712316

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Local Institution - 0685, Fenton

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06875310

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

St. Lukes Hosp. of Kansas City /ID# 259940, Kansas City
Hulston Cancer Center /ID# 232226, Springfield

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT04928846

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Washington University School of Medicine, St Louis

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Washington University, St Louis

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Bridgeton
Research Site, Kansas City

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Kansas City
Clinical Study Site, St Louis
Clinical Study Site, St Louis

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06767514

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Washington University School of Medicine, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06855771

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Washington University, St Louis

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT05786924

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Washington University-School of Medicine /ID# 262759, St Louis

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06236438

A Study of KK2269 in Adult Participants With Solid Tumors

Washington University, St Louis

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06266299

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Ellis Fischel Cancer Center, Columbia
Siteman Cancer Center - Washington University Medical Campus, St Louis

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT04302025

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

St. Lukes Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06625775

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.